NCT06583564View on ClinicalTrials.gov

The Prognosis Effect of Indocyanine Green (ICG) Fluorescence Guided Surgery on Disease-free Survival (DFS) of Stage III Colorectal Cancer

NANot yet recruitingINTERVENTIONAL

Enrollment

192

Participants

Timeline

Start Date

September 27, 2024

Primary Completion Date

March 31, 2025

Study Completion Date

March 31, 2025

Conditions

Colorectal Cancer Stage III

Interventions

PROCEDURE

ICG lymphangiography procedure

All patients underwent standard complete mesocolic excision (CME) or total mesorectal excision (TME) with curable purpose using ICG lymphangiography procedure

Trial Locations (1)

200336

Shanghai Tongren Hospital, Changning

All Listed Sponsors

lead

Shanghai Tong Ren Hospital

OTHER

NCT06583564 - The Prognosis Effect of Indocyanine Green (ICG) Fluorescence Guided Surgery on Disease-free Survival (DFS) of Stage III Colorectal Cancer | Biotech Hunter | Biotech Hunter